Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (53) Cystic Fibrosis
...CenterWatch: Clinical Trials in Category (53) Cystic Fibrosis Cystic Fibrosis State • New Jersey • New York • North Dakota New Jersey Morristown : Atlantic Health System ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (53), Cystic Fibrosis
...CenterWatch: New Medical Therapies in Disease Category (53), Cystic Fibrosis Cystic Fibrosis Patient Medical Areas • Pulmonary/Respiratory Diseases May 11, 2009 Pharmaxis issued positive results ...
View Page

3.  Study Posting (1044) Trial #155086, Cystic Fibrosis, Bismarck, ND
...Study Posting (1044) Trial #155086, Cystic Fibrosis, Bismarck, ND Trial Information A study for patients with cystic fibrosis A study of an ...
View Page

4.  Study Posting (1044) Trial #155085, Cystic Fibrosis, Bismarck, ND
...Study Posting (1044) Trial #155085, Cystic Fibrosis, Bismarck, ND Trial Information Study of an investigational treatment for patients with Cystic Fibrosis The ...
View Page

5.  Study Posting (77) Trial #128283, Cystic Fibrosis, Great Neck, NY
...Study Posting (77) Trial #128283, Cystic Fibrosis, Great Neck, NY Trial Information Inhalation Solution for Patients with Cystic Fibrosis Lung Disease - Adults ...
View Page

6.  Study Posting (77) Trial #157583, Cystic Fibrosis, New Hyde Park, NY
...Study Posting (77) Trial #157583, Cystic Fibrosis, New Hyde Park, NY Trial Information Inhalation Solution for Patients with Cystic Fibrosis Lung Disease ...
View Page

7.  Study Posting (1570) Trial #156494, Cystic Fibrosis, Morristown, NJ
...Study Posting (1570) Trial #156494, Cystic Fibrosis, Morristown, NJ Trial Information Safety, Tolerability and Efficacy of MP-376 Given for 28 Days ...
View Page

8.  Study Posting (77) Trial #155042, Cystic Fibrosis, New Hyde Park, NY
...Study Posting (77) Trial #155042, Cystic Fibrosis, New Hyde Park, NY Trial Information A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel ...
View Page

9.  Study Posting (1570) Trial #156492, Cystic Fibrosis, Morristown, NJ
...Study Posting (1570) Trial #156492, Cystic Fibrosis, Morristown, NJ Trial Information Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in ...
View Page

10.  Study Posting (1570) Trial #156583, Cystic Fibrosis, Morristown, NJ
...Study Posting (1570) Trial #156583, Cystic Fibrosis, Morristown, NJ Trial Information Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis ...
View Page

11.  Study Posting (1570) Trial #156495, Cystic Fibrosis, Morristown, NJ
...Study Posting (1570) Trial #156495, Cystic Fibrosis, Morristown, NJ Trial Information Safety and Efficacy of 12-wk Treatment With Two Doses of ...
View Page

12.  Study Posting (1570) Trial #156576, Cystic Fibrosis, Morristown, NJ
...Study Posting (1570) Trial #156576, Cystic Fibrosis, Morristown, NJ Trial Information Use of Formula Fortified With DHA in Infants With Cystic Fibrosis ...
View Page

13.  Study Posting (77) Trial #118897, Respiratory Failure, New Hyde Park, NY
...Study Posting (77) Trial #118897, Respiratory Failure, New Hyde Park, NY Trial Information Cystic Fibrosis and Pseudomonas aeruginosa Airway Infection - Adults People with cystic fibrosis and Pseudomonas aeruginosa airway infection ...
View Page

14.  Newly Approved Drug Therapies (195) Pulmozyme (dornase alfa), Genentech,
...presentations. Drug Name: Pulmozyme (dornase alfa) Company: Genentech Approval Status: Approved December 1996 Treatment Area: cystic fibrosis General Information Pulmozyme Inhalation Solution has been approved for the treatment of cystic fibrosis patients ...
View Page

15.  Study Posting (4519) Trial #124464, Cytomegalovirus Infections, Pittsburgh, PA
...Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

16.  Study Posting (4519) Trial #124246, Cytomegalovirus Infections, Cleveland, OH
...Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

17.  Study Posting (4519) Trial #123579, Cytomegalovirus Infections, Durham, NC
...Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

18.  Study Posting (4519) Trial #123966, Cytomegalovirus Infections, Los Angeles, CA
...Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

19.  Newly Approved Drug Therapies (372) Tobi, PathoGenesis,
...medical conference presentations. Drug Name: Tobi Company: PathoGenesis Approval Status: Approved December 1997 Treatment Area: cystic fibrosis General Information Tobi (tobramycin) has been approved as an inhaled antibiotic for the treatment of ...
View Page

20. Clinical Trial Results by Drug Names
...study of ganciclovir from the pro-drug, valganciclovir, in lung transplant recipients with or without cystic fibrosis. Fast Facts: Protocol number: WP18046 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Product name: Valcyte ...
View Page